Jerusalem, June 2, 2010 - Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVA) today announced U.S. Food and Drug Administration (FDA) approval and commercial launch of its generic version of Galderma's ...
MELVILLE, N.Y. The Food and Drug Administration has approved a topical drug for acne made by E. Fougera, the generic drug maker said Tuesday. The FDA approved Fougera’s adapalene cream in the 0.1% ...
July 12, 2010 — The US Food and Drug Administration (FDA) has approved the first generic formulation of adapalene 0.1% cream (E. Fougera & Company; brand name Differin, made by Galderma ...
PRINCETON, N.J. — Sandoz on Monday announced the introduction of its adapalene 0.3% gel, a generic version of Differin gel, 0.3% from Galderma Labs. Adapalene gel is a retinoid and is used for the ...
Adapalene 0.1%; alcohol-free. Discontinue if allergic reaction occurs or no improvement after 3 months. Do not use on cuts, abrasions, eczematous, or sunburned skin. Avoid eyes, lips, mouth, sun, UV ...
Adapalene 0.1%; alcohol-free. Biochemical and pharmacological profile studies have demonstrated that adapalene is a modulator of cellular differentiation, keratinization, and inflammatory processes.
JERUSALEM--(BUSINESS WIRE)-- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) today announced U.S. Food and Drug Administration (FDA) approval and commercial launch of its generic version of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results